Sage Journals: Discover world-class research

Free access

Other

First published 2009-04

Coadministration of muraglitazar plus glyburide: Improvement of glycaemic and lipid profiles in patients with type 2 diabetes

Cindy J. Rubin, Veerle De Pril, Fred T. Fiedorek

Diabetes & Vascular Disease Research

Free access

Other

First published 2009-07

Efficacy and safety of muraglitazar: a double-blind,24-week,dose-ranging study in patients with type 2 diabetes

Cindy J. Rubin, Kalyanee Viraswami-Appanna, Fred T. Fiedorek

Diabetes & Vascular Disease Research

Free access

Research article

First published 2008-09

Improvement of glycaemic and lipid profiles with muraglitazar plus metformin in patients with type 2 diabetes: an active-control trial with glimepiride

Cindy J Rubin, Jean-Marie Ledeine, Fred T Fiedorek

Diabetes & Vascular Disease Research

Retricted access

Other

First published 2006-05

Goodbye glitazars?

Deane Conlon

The British Journal of Diabetes & Vascular Disease

Free access

Research article

First published 2006-12

Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar,a PPARα/γ Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action

Mark A. Dominick, Melvin R. White, Thomas P. Sanderson [...]

Toxicologic Pathology

Retricted access

Research article

First published 2007-6

Evolution of Peroxisome Proliferator-Activated Receptor Agonists

Feng Chang, Linda A Jaber, Helen D Berlie [...]

Annals of Pharmacotherapy

Retricted access

Review article

First published 2005-9

Entecavir

Dennis J. Cada, Terri Levien, Danial E. Baker

Hospital Pharmacy

Free access

Research article

First published 2012-7

The Development of Subcutaneous Sarcomas in Rodents Exposed to Peroxisome Proliferators Agonists

Ingrid M. Pruimboom-Brees, Omar Francone, John C. Pettersen [...]

Toxicologic Pathology

Retricted access

Research article

First published 2007-12

Reporting On Adverse Clinical Events

Clin-Alert

Search results